| 前收市價 | 96.86 |
| 開市 | 97.02 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 95.91 - 98.85 |
| 52 週波幅 | 88.00 - 188.99 |
| 成交量 | |
| 平均成交量 | 633,273 |
| 市值 | 23.569B |
| Beta 值 (5 年，每月) | 0.24 |
| 市盈率 (最近 12 個月) | 5.16 |
| 每股盈利 (最近 12 個月) | 19.04 |
| 業績公佈日 | 2023年11月06日 |
| 遠期股息及收益率 | 2.11 (1.32%) |
| 除息日 | 2022年6月02日 |
| 1 年預測目標價 | 143.10 |
Yahoo FinanceAWS expands big pharma partnerships in manufacturing, AI, and R&D
Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.
InvestorPlace3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and save many lives. In fact, the global biotechnology market is currently valued at $1.22 trillion and is expected to grow to $3.21 trillion by 2030. That shows a possible compound annual growth rate of 12.8%. In comparison, the S&P 500 has a growth rate of 9.51% per year. Plus, biotech industry revenue i
InvestorPlace7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader pressures, generally manages to march to its own beat, the underlying innovation may offer an alternative upside pathway. By now, you’ve likely heard about the impressive third-quarter U.S. GDP print, which came in hotter than expected. But looking ahead, circumstances don’t seem so rosy to justify belief in a repeat performance.
